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    The relationships between host immunocompetence in 68 patients with bladder carcinoma （Me＝＝
64 years old） and tumor stage， tumor grade， as well as three years survival have been studied． The
host immunecompetence was investigated by the following methods： the first was a delayed cutaneous
hypersensitivity tesit using 2－4－dinitrechlorobenzene （DNCB） test， the second one was a tuberculin
（PPD） test， the third’was degree ef blastogenesis of lymphocytes in vitro using phytohernagglutipin
（PHA－P）， and ’the ・forth was peripheral lymphocyte counts． The 63 carcinoma cases consisted of
47 c．a． ses．．e．f transitional cel！ ¢4；．cihqma， 4 ef squamous cell carcinoma， 7 ef undifferentiated carcinoma，
i of adenocarcinoma， and 4 unknown cases． According to Jewett and Marshall’s staging and AFIP’s
grading， the 63 carcinoma cases were divided into： 26 cases of stage A， ．14 of stage B， 11 of stage C，
and 12 of stage D； 7 cases ef grade 1， 25 of grade II， 16 of grade III， 8 of grade IV， and 7 unknown
cases．
    In the control groups with benign diseases， the DNCB tests were positive in all 22 cases （Me＝＝＝
60）， the degree of blastogenesis of lymphocytes had a mean value of 600／． in 10 cases （Me＝3．5）， and
peripherai lymphocyte counts had a mean value Qf 2，IOOImm in 23 cases 〈Mei＝48）． The coTrela－
tions of turnor stage with the DNCB test， the PPD test， and the degree．of blastbgenesis gg lyrriphocYtes
wcrg higbly・ig・ifi・・pt（Pく0・Oi）wh・n cal・・1・t・d by・hi一・q・・re t・・t・．But th・c6rrel・ti・nρf t…・
stage with peripheral lymphocytes was pot’唐奄№獅奄?奄モ≠獅煤D Concerning tumor grade， the eorrelations
of tumor grade with ．the P．PD test， and the d．¢gr．ee of blastogenesis of lymphocytes were ・highly signifi－
cant（Pく0・01）・ The correlation of tumor grade with DNCB test was signi且cant（P＜0．．02）， but
the cot．relatig．p． of tum．f T． gTaqe with peri？heral ！yn｝phocytes was not significant．
    The correlations of peripheral lymphocyte’ counts with DNCB test and PPD test showed P〈
O．02 and P〈Q．O！， respectively， by t－test， The correlation of the degree of blastogenesis．of lymphocytes
wi由the DNCB tes坤howed Pく0・0玉．as calculated by t－test， but the relationships betwcen degrec of
blastogenesis of lymphocytes and PPD test was not significant．
    There were 20 deaths and 9 recurrences of bladder carcinoma during ．the follow－up period of
’36 months． Sixteen patients survived the period without evidence ef recurrence． lmpaired im－
munocompetence was outstanding in the 20 dead patients． The DNCB test was negative in 840／o
of them（P＜0．0王）， the PPD test was negative in＄9％of them（Pく0．05）， the value df degrとe Qf blasto－
genesis of lyinph6cytes was’@less than 500／， in all （P〈O．05）， and．the value of peripheral lymphocyte
counts was less．狽?≠?l，000／m皿in 30％of them（not significant）． The relat圭ve numbcr of i血paired
host iminunoeompetence cases among the recurrence group and the group withovt evidence of recur－
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Table 5． Age distribution in control groups．




































65 patients wlth bladder cancer
Male ： 51’o 29一・80 years of age）
Female： 12（53 ・一81 year＄ of oge｝
Me． 64 years of age
， Table 2． Histological classification．
M． F． T．＊
Transitional C． 59 8 47
Squamous C． 5 t 4
Undiff． C． 5 2 7
Adenocarclnorna ｝ O 1Unknown 5 1 4
Toto1 55 12 es
Me 66 5555 48
    ＊ M：male， F： femole， T： totai
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Fig． 2． Relationship between PPD test aiid
    age disnibution in the non－malignant
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Fig． 3． Relationship between degree of blasto－
    genesis of lymphocytes and age distri－
    bution in the non一皿aJignant group・
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Fig． 1． Relationship between DNCB test and
    age distribution in the non－malignant
    patient group．
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Fig． 4． Relationship between periphera！ lym－
    phocyte count a nd age distribution in
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      lZ2＝7Q3， DF＝16， PくQO【，n＝84｝
Fig． 5． Relationship．’between tumor stage and
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Fig． 6． Relationship between tumor stage and
    PPD．
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Fig． 7． Relationship between tumor stage and









































                Stege
Contrel 一A B C D    （ F（646）＝O．90， Ns）





































































   ．
                    Grade
    Conサrol    I     江     皿     皿
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Fig． 10． Relationship between tumor grade


























                    Grade    Control r E M N
      ｛Z223L2， DF＝16， PくO．02， n＝77｝
Fig． 9． Relationship between tumor grade and
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       〔F（幽｝・5・79・・PくQOI）
Fig． 11． Relationship between tumor grade and
    degree of blastogenesis by PHA．
Grade I群の2例で54．0±4・2％， Grade H群の7例
で49．7±14．5％，Gradc皿群の6例では48．2±10．4％，
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Fig． 12． Relationship between tumor grade and
     peripheral lymphocyte count．






























    O－PPD          Negative Positlve
        （t＝L26， DF＝22， NS）
Fig．正4． Relationship between PPD and degree














  Negative Positive
（t＝765，DF＝20， PくO．Ol）
Relationship between DNCB and degree
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Fig． 15． Relationship between DNCB and
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       〔t＝3．49，DF＝62，PくQOl）
Fig． 16． Relationship between PPD and






























Table 6．Interrelationship among therapy， S6－month prognesis and impaired
host immunocompetence．
Therapy Case Stage DNCBPPD Biast． lyrnph． 56rn－prognosis
Total cystectomy 18 D 2 1／2（50）
          C8 6／7（86）
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Relationship between 36－month prognosis and impaired host
immunoc，ompetence．
36M－prognosis No，Pts DNCB（Ole） P P D（Olo） Blast， COIo） lyrnph．（Ol，｝





















Tota1 65 22／62｛55） 35／60（58） 12／29（41） 8／61（15）
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